Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PLA2G1B | P04054 | 1/20 | 0.62 |
| ▸ | PLA2G2A | P14555 | 1/20 | 0.62 |
| ▸ | S1PR2 | O95136 | 5/20 | 0.61 |
| ▸ | S1PR1 | P21453 | 5/20 | 0.61 |
| ▸ | S1PR3 | Q99500 | 5/20 | 0.61 |
| ▸ | S1PR4 | O95977 | 4/20 | 0.61 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.60 |
| ▸ | SPHK1 | Q9NYA1 | 2/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.52 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.50 |
| ▸ | LMNA | P02545 | 2/20 | 0.50 |
| ▸ | GMNN | O75496 | 1/20 | 0.50 |
| ▸ | POLB | P06746 | 1/20 | 0.50 |
| ▸ | THPO | P40225 | 1/20 | 0.50 |
| ▸ | MTOR | P42345 | 1/20 | 0.50 |
| ▸ | BLM | P54132 | 1/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.50 |
| ▸ | TP53 | P04637 | 1/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10447807 | 1.00 | PLA2G1B (0.62) | PLA2G1BPLA2G2AS1PR2S1PR1S1PR3 | |
| SCHEMBL10448552 | 1.00 | PLA2G1B (0.62) | PLA2G1BPLA2G2AS1PR2S1PR1S1PR3 | |
| SCHEMBL4952280 | 1.00 | PLA2G1B (0.62) | PLA2G1BPLA2G2AS1PR2S1PR1S1PR3 | |
| SCHEMBL1507463 | 1.00 | PLA2G1B (0.62) | PLA2G1BPLA2G2AS1PR2S1PR1S1PR3 | |
| SCHEMBL20746344 | 1.00 | PLA2G1B (0.62) | PLA2G1BPLA2G2AS1PR2S1PR1S1PR3 | |
| SCHEMBL20746505 | 1.00 | PLA2G1B (0.62) | PLA2G1BPLA2G2AS1PR2S1PR1S1PR3 | |
| SCHEMBL23141152 | 1.00 | PLA2G1B (0.62) | PLA2G1BPLA2G2AS1PR2S1PR1S1PR3 | |
| SCHEMBL8980625 | 1.00 | PLA2G1B (0.62) | PLA2G1BPLA2G2AS1PR2S1PR1S1PR3 | |
| SCHEMBL20746346 | 1.00 | PLA2G1B (0.62) | PLA2G1BPLA2G2AS1PR2S1PR1S1PR3 | |
| SCHEMBL20746426 | 1.00 | PLA2G1B (0.62) | PLA2G1BPLA2G2AS1PR2S1PR1S1PR3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7067687-B2 | Ultrastable organofunctional microporous to mesoporous silica compositions | BOARD OF TRUSTEES OF MICHIGAN STATE UNIVERSITY (US) | 2006-06-27 | — | — | US | disclosed |
| US-20040171482-A1 | Ultrastable organofunctional microporous to mesoporous silica compositions | BOARD OF TRUSTEES OF MICHIGAN STATE UNIVERSITY | 2004-09-02 | — | — | US | disclosed |
| US-6713643-B2 | USEFUL AS MOLECULAR SIEVES, SUPPORTS FOR CATALYSTS AND OTHER APPLICATIONS REQUIRING AN ORGANO GROUP ON SURFACES OF A SILICA | BOARD OF TRUSTEES OF MICHIGAN STATE UNIVERSITY | 2004-03-30 | — | — | US | disclosed |
| US-20030054948-A1 | Ultrastable organofunctional microporous to mesoporous silica compositions | BOARD OF TRUSTEES OPERATING MICHIGAN STATE UNIVERSITY (US) | 2003-03-20 | — | — | US | disclosed |
| WO-2002100526-A2 | ULTRASTABLE ORGANOFUNCTIONAL MICROPOROUS TO MESOPOROUS SILICA COMPOSITIONS | MICHIGAN STATE UNIVERSITY (US) | 2002-12-19 | — | — | WO | disclosed |
| EP-0167969-B1 | TRIS-ORGANOPHOSPHITE COMPOSITIONS HAVING IMPROVED HYDROLYTIC STABILITY | Argus Chemical Corporation (US) | 1989-09-13 | — | — | EP | disclosed |
| US-4707509-A | Tris-organophosphite compositions having improved hydrolytic stability | ARGUS CHEMICAL CORPORATION (US) | 1987-11-17 | — | — | US | disclosed |
| EP-0143464-B1 | PENTAERYTHRITOL-SPIRO-BIS-PHOSPHITE COMPOSITIONS HAVING IMPROVED HYDROLYTIC STABILITY | Argus Chemical Corporation (US) | 1987-07-08 | — | — | EP | disclosed |
| US-4650894-A | STABILIZERS FOR VINYL CHLORIDE POLYMERS | ARGUS CHEMICAL CORPORATION (US) | 1987-03-17 | — | — | US | disclosed |
| EP-0167969-A2 | Tris-organophosphite compositions having improved hydrolytic stability | Argus Chemical Corporation (US) | 1986-01-15 | — | — | EP | disclosed |
| EP-0143464-A2 | Pentaerythritol-spiro-bis-phosphite compositions having improved hydrolytic stability | Argus Chemical Corporation (US) | 1985-06-05 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030054948-A1 | Ultrastable organofunctional microporous to mesoporous silica compositions | LPO, SPIN3, RPS3 | PLA2G1B 4174/4885PLA2G2A 3880/4885S1PR2 1326/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.